稿を終えるにあたり、御懇篤なる御指導を頂きました中村誠司教授に深甚な る謝意を表します。また直接御指導頂きました林田淳之將助教、森山雅文先生 に深謝致します。また、常に励ましの言葉を頂きました九州大学大学院歯学研 究院口腔顎顔面病態学講座顎顔面腫瘍制御学分野の皆様に深く感謝致します。
参考文献
1. Morgan WS and Castleman B. A clinicopathologic study of Mikulicz's disease.
Am J Pathol 1953;29:471-503.
2. Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al.
Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology (Oxford) 2005;44:227-34.
3. Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al.
A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006;16:335-40.
4. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
5. 山本元久, 小原美琴子, 鈴木知佐子, 岡俊州, 苗代康可, 山本博幸, et al.
ステロイド療法により耐糖能障害の改善を認めた自己免疫性膵炎合併 Mikulicz病の1例. 日本臨床免疫学会雑誌(0911-4300) 2005;28:349-56.
6. Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, et al.
Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc 2005;62:152-7.
7. Saeki T, Nishi S, Ito T, Yamazaki H, Miyamura S, Emura I, et al. Renal lesions in IgG4-related systemic disease. Intern Med 2007;46:1365-71.
8. 崎山幸雄. IgGサブクラス欠乏症. Medical Immunology 1989;17:105-10.
9. Spiegelberg HL. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol 1974;19:259-94.
10. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, and Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol
1998;160:3555-61.
11. Meiler F, Klunker S, Zimmermann M, Akdis CA, and Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors.
Allergy 2008;63:1455-63.
12. Satoguina JS, Weyand E, Larbi J, and Hoerauf A. T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J Immunol 2005;174:4718-26.
13. Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538-46.
14. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, and Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
15. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, and Hofman FM.
Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci U S A 1992;89:574-8.
16. Kennedy MK, Torrance DS, Picha KS, and Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992;149:2496-505.
17. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, et al.
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993;178:87-99.
18. Ohyama Y, Nakamura S, Matsuzaki G, Shinohara M, Hiroki A, Fujimura T, et al.
Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 1996;39:1376-84.
19. Infante-Duarte C, Horton HF, Byrne MC, and Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000;165:6107-15.
20. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000;164:2832-8.
21. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, and Bos JD.
Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998;111:645-9.
22. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic
self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-62.
23. Luster AD. Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
24. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, et al. Lymphotactin: a cytokine that represents a new class of chemokine.
Science 1994;266:1395-9.
25. Rabin RL, Park MK, Liao F, Swofford R, Stephany D, and Farber JM.
Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol 1999;162:3840-50.
26. Murdoch C and Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000;95:3032-43.
27. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, and Serody JS. Leukocyte migration and graft-versus-host disease. Blood 2005;105:4191-9.
28. Haskell CA, Hancock WW, Salant DJ, Gao W, Csizmadia V, Peters W, et al.
Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection. The Journal of Clinical Investigation 2001;108:679-88.
29. Kim SH, Cleary MM, Fox HS, Chantry D, and Sarvetnick N. CCR4-bearing T cells participate in autoimmune diabetes. J Clin Invest 2002;110:1675-86.
30. Yamagami S, Ebihara N, and Amano SY. Chemokine receptor gene expression in giant papillae of atopic keratoconjunctivitis. Mol Vis 2005;11:192-200.
31. Wenzel J, Henze S, Worenkamper E, Basner-Tschakarjan E,
Sokolowska-Wojdylo M, Steitz J, et al. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for
lymphocyte recruitment in cutaneous lupus erythematosus. J Invest Dermatol 2005;124:1241-8.
32. Sorensen TL, Ransohoff RM, Strieter RM, and Sellebjerg F. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur J Neurol 2004;11:445-9.
33. Ogawa N, Ping L, Zhenjun L, Takada Y, and Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines,
interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with
Sjogren's syndrome. Arthritis Rheum 2002;46:2730-41.
34. Ogawa N, Kawanami T, Shimoyama K, Ping L, and Sugai S. Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjogren's syndrome. Clin Immunol 2004;112:235-8.
35. Greenspan JS, Daniels TE, Talal N, and Sylvester RA. The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974;37:217-29.
36. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, and Tsubota K. Recised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol 2004;14:425-34.
37. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
38. Yamamoto M, Takahashi H, and Shinomura Y. Mikulicz's disease and its extraglandular lesions. Curr Immunol Rev.;in press:
39. 高橋裕樹, 山本元久, 日本シェーグレン症候群研究会 編, 住田孝之 監, and 江口勝美. IgG4関連疾患. シェーグレン症候群の診断と治療マニュア ル 2009p172-84.
40. 石川梧朗, 小守昭, and 他. sjögren 症候群における口唇腺生検の診断的価 値. 日本口腔科学会誌 1979;38:3-6.
41. Rubin P and Holt JF. Secretory sialography in diseases of the major salivary glands. Am J Roentgenol Radium Ther Nucl Med 1957;77:575-98.
42. Hiroki A, Nakamura S, Shinohara M, Gondo H, Ohyama Y, Hayashi S, et al. A comparison of glandular involvement between chronic graft-versus-host disease and Sjogren's syndrome. Int J Oral Maxillofac Surg 1996;25:298-307.
43. Nakamura S, Hiroki A, Shinohara M, Gondo H, Ohyama Y, Mouri T, et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
1996;82:556-63.
44. Ohyama Y, Nakamura S, Matsuzaki G, Shinohara M, Hiroki A, Oka M, et al.
T-cell receptor V alpha and V beta gene use by infiltrating T cells in labial glands of patients with Sjogren's syndrome. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod 1995;79:730-7.
45. Mouri T, Nakamura S, Ohyama Y, Matsuzaki G, Shinohara M, Kishihara K, et al.
T cell receptor V alpha and V beta gene usage by tumour-infiltrating
lymphocytes in oral squamous cell carcinoma. Cancer Immunol Immunother 1996;43:10-8.
46. Sasaki M, Nakamura S, Ohyama Y, Shinohara M, Ezaki I, Hara H, et al.
Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjogren's syndrome. J Immunol 2000;164:2823-31.
47. Kawamura E, Nakamura S, Sasaki M, Ohyama Y, Kadena T, Kumamaru W, et al.
Accumulation of oligoclonal T cells in the infiltrating lymphocytes in oral lichen planus. J Oral Pathol Med 2003;32:282-9.
48. Sumida T, Matsumoto I, Maeda T, and Nishioka K. T-cell receptor in Sjogren's syndrome. Br J Rheumatol 1997;36:622-9.
49. Yamamoto M, Takahashi H, Sugai S, and Imai K. Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy).
Autoimmun Rev 2005;4:195-200.
50. Kong L, Ogawa N, Nakabayashi T, Liu GT, D'Souza E, McGuff HS, et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 1997;40:87-97.
51. Mosmann TR and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-46.
52. Coutinho A BA. Tolerize one, tolerze them all: tolerance is self-assertion.
Immunol today 1989;10:264-6.
53. Nguyen CQ, Hu MH, Li Y, Stewart C, and Peck AB. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum 2008;58:734-43.
54. Miyake K, Moriyama M, Aizawa K, Nagano S, Inoue Y, Sadanaga A, et al.
Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion. Mod Rheumatol 2008;18:86-90.
55. Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, et al.
Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a
central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000;165:6590-8.
56. Lee EY, Lee ZH, and Song YW. CXCL10 and autoimmune diseases.
Autoimmun Rev 2009;8:379-83.
57. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaez A, Davila-Maldonado L, Atisha-Fregoso Y, Llorente L, et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007;56:1242-50.
58. Miyahara H, Okazaki N, Nagakura T, Korematsu S, and Izumi T. Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy. Clin Exp Allergy 2010
59. Moser B, Wolf M, Walz A, and Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol 2004;25:75-84.
60. Aalberse RC and Schuurman J. IgG4 breaking the rules. Immunology 2002;105:9-19.
61. Okazaki K, Uchida K, and Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol 2008;43:409-18.
62. Yamada K, Kawano M, Inoue R, Hamano R, Kakuchi Y, Fujii H, et al. Clonal relationship between infiltrating immunoglobulin G4 (IgG4)-positive plasma cells in lacrimal glands and circulating IgG4-positive lymphocytes in Mikulicz's disease. Clin Exp Immunol 2008;152:432-9.
63. Kojima M, Sipos B, Klapper W, Frahm O, Knuth HC, Yanagisawa A, et al.
Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol 2007;31:521-8.
64. Chang MC, Chang YT, Tien YW, Liang PC, Jan IS, Wei SC, et al. T-cell
regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin Chem 2007;53:1700-5.
65. Umemura T and Higashi Y. Endothelial progenitor cells: therapeutic target for cardiovascular diseases. J Pharmacol Sci 2008;108:1-6.
66. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al.
CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008;322:271-5.